» Articles » PMID: 30700170

Changes in Inflammatory Bowel Disease Subtype During Follow-up and over Time in 44,302 Patients

Overview
Publisher Informa Healthcare
Specialty Gastroenterology
Date 2019 Feb 1
PMID 30700170
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate inflammatory bowel disease (IBD) register-based subtype classifications over a patient's disease course and over time.

Methods: We examined International Classification of Diseases coding in patients with ≥2 IBD diagnostic listings in the National Patient Register 2002-2014 (n = 44,302).

Results: 18% of the patients changed diagnosis (17% of adults, 29% of children) during a median follow-up of 3.8 years. Of visits with diagnoses of Crohn's disease (CD) or ulcerative colitis (UC), 97% were followed by the same diagnosis, whereas 67% of visits with diagnosis IBD-unclassified (IBD-U) were followed by another IBD-U diagnosis. Patients with any diagnostic change changed mostly once (47%) or twice (31%), 39% from UC to CD, 33% from CD to UC and 30% to or from IBD-U. Using a classification algorithm based on the first two diagnoses ('incident classification'), suited for prospective cohort studies, the proportion adult patients with CD, UC, and IBD-U 2002-2014 were 29%, 62%, and 10% (43%, 45%, and 12% in children). A classification model incorporating additional information from surgeries and giving weight to the last 5 years of visits ('prevalent classification'), suited for description of a study population at end of follow-up, classified 31% of adult cases as CD, 58% as UC and 11% as IBD-U (44%, 38%, and 18% in children).

Conclusions: IBD subtype changed in 18% during follow-up. The proportion with CD increased and UC decreased from definition at start to end of follow-up. IBD-U was more common in children.

Citing Articles

Childhood-onset inflammatory bowel disease and chronic non-bacterial osteomyelitis: a Swedish nationwide cohort study 2002-2022.

Malmquist M, Voghera S, Berg S, Saalman R, Olen O J Crohns Colitis. 2025; 19(2).

PMID: 39804716 PMC: 11791680. DOI: 10.1093/ecco-jcc/jjaf007.


Prevalence of Inflammatory Bowel Disease Unclassified, as Estimated Using the Revised Porto Criteria, among Korean Pediatric Patients with Inflammatory Bowel Disease.

Lee S, Shin M, Kim S, Kim S, Yoon H, Park Y Pediatr Gastroenterol Hepatol Nutr. 2024; 27(4):206-214.

PMID: 39035400 PMC: 11254648. DOI: 10.5223/pghn.2024.27.4.206.


Risk of Kidney Failure in Patients With Inflammatory Bowel Disease Undergoing Colectomy: A Nationwide Cohort Study.

Yang Y, Ludvigsson J, Forss A, Faucon A, Faye A, Olen O Clin Gastroenterol Hepatol. 2024; 22(11):2291-2298.e17.

PMID: 38777172 PMC: 11512676. DOI: 10.1016/j.cgh.2024.05.010.


Farming Activities and Risk of Inflammatory Bowel Disease: A French Nationwide Population-based Cohort Study.

Petit P, Leroyer A, Chamot S, Fumery M, Bonneterre V J Crohns Colitis. 2024; 18(9):1415-1429.

PMID: 38605515 PMC: 11369074. DOI: 10.1093/ecco-jcc/jjae050.


Predictive biomarkers for anti-TNF alpha therapy in IBD patients.

Kumar M, Murugesan S, Ibrahim N, Elawad M, Al Khodor S J Transl Med. 2024; 22(1):284.

PMID: 38493113 PMC: 10943853. DOI: 10.1186/s12967-024-05058-1.